Clinical Trial Update: FLAT Study: First Line Ablation Therapy for Treatment of Paroxysmal Atrial Fibrillation (RAAFT) [Phase 3]

View source ↗

Summary

The FLAT Study (RAAFT) Phase 3 trial evaluating first-line ablation therapy for paroxysmal atrial fibrillation has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation
• Paroxysmal Atrial Fibrillation

Snippet

Sponsor: Biosense Webster EMEA | Conditions: Atrial Fibrillation | Phase 3 | Status: COMPLETED